FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.360
-0.070 (-4.90%)
Apr 28, 2026, 4:00 PM EDT - Market closed
FibroBiologics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.24 | 9.23 | 6.52 | 3.32 | 1.06 | |
| Research & Development | 7.41 | 4.5 | 2.37 | 1.15 | 0.52 | |
| Operating Expenses | 16.65 | 13.74 | 8.89 | 4.47 | 1.58 | |
| Operating Income | -16.65 | -13.74 | -8.89 | -4.47 | -1.58 | |
| Interest Expense | -0.2 | -0.02 | -0.15 | -0.65 | -0 | |
| Interest & Investment Income | 0.25 | 0.25 | - | - | - | |
| Other Non Operating Income (Expenses) | -2.04 | 2.35 | -7.45 | - | - | |
| Pretax Income | -18.65 | -11.16 | -16.49 | -5.12 | -1.58 | |
| Net Income | -18.65 | -11.16 | -16.49 | -5.12 | -1.58 | |
| Preferred Dividends & Other Adjustments | - | - | 2.57 | - | - | |
| Net Income to Common | -18.65 | -11.16 | -19.06 | -5.12 | -1.58 | |
| Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 0 | |
| Shares Change (YoY) | 35.85% | 16.45% | - | 222.64% | - | |
| EPS (Basic) | -8.35 | -6.79 | -13.50 | -3.63 | -3.62 | |
| EPS (Diluted) | -8.35 | -6.79 | -13.50 | -3.63 | -3.62 | |
| Free Cash Flow | -16.66 | -12.09 | -6.9 | -4.07 | -1.41 | |
| Free Cash Flow Per Share | -7.46 | -7.35 | -4.88 | -2.88 | -3.22 | |
| EBITDA | -16.41 | -13.58 | -8.84 | - | - | |
| D&A For EBITDA | 0.24 | 0.16 | 0.05 | - | - | |
| EBIT | -16.65 | -13.74 | -8.89 | -4.47 | -1.58 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.